8-K

Company

X4 Pharmaceuticals, Inc

Filed

April 15, 2019

Period of Report

April 12, 2019

Accession Number

0001193125-19-106621

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →